EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Adjunctive Systemic Amoxicillin and Metronidazole Following Surgical Peri‐Implantitis Treatment: A Single‐Blind Randomised Controlled Trial With a 1‐Year Follow‐Up

Jarno Hakkers iD, Yvonne C M de Waal iD, Barzi Gareb, Henny J A Meijer iD, Gerry M Raghoebar iD

Journal of Clinical Periodontology · 2026-04 · 53 (4) · 550-561

DOI: 10.1111/jcpe.70100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 13.01.2026. Verfasst von Jarno Hakkers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Metronidazole, Amoxicillin, Peri-Implantitis, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, Universitair Medisch Centrum Groningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To analyse the effect of systemic amoxicillin and metronidazole on surgical peri‐implantitis treatment with a follow‐up period of 1 year. Materials and Methods Fifty‐nine patients were randomly assigned to receive peri‐implantitis surgery supplemented with (29 patients; test) or without (30 patients; control) systemic amoxicillin and metronidazole, in cases with no, one‐wall or two‐wall bony defects. Primary outcomes were mean peri‐implant probing pocket depth (PPD) and mean peri‐implant bleeding on probing (BOP); secondary outcomes included disease resolution (composite treatment outcome: residual probing depths ≤ 5 mm; no BOP in one or more probing site; no suppuration on probing), suppuration on probing (SOP) and radiographic marginal bone levels (MBLs), evaluated 3, 6, 9 and 12 months postoperatively (T3, T6, T9, T12). Linear and logistic mixed‐effects models were employed.

Results

Between‐group analyses showed that BOP was significantly lower in the test group compared to the control group at T9 (β = −10.57%, 95% CI: −20.17 to −0.97, p = 0.03) and T12 (β = −14.47%, 95% CI: −25.9 to −3.04, p = 0.01). No other parameters in the mixed‐effects models showed statistically significant differences between groups at any timepoint.

Conclusion

Access‐flap peri‐implantitis surgery supplemented with systemic amoxicillin and metronidazole led to a statistically significant reduction in peri‐implant BOP after 1 year, whereas no other parameters showed statistically significant differences between groups at any timepoint. The clinical implications of these differences should be interpreted with caution, as the isolated short‐term effect does not translate into broader or sustained clinical benefit and must be weighed against the risks associated with systemic antibiotic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleAmoxicillinPeri-ImplantitisAnti-Bacterial AgentsAnti-Infective AgentsHumansSingle-Blind MethodFollow-Up StudiesFemaleMaleTreatment OutcomeMiddle AgedAlveolar Bone LossPeriodontal PocketAgedSuppurationPeriodontal Index

Substanzen

MetronidazoleAmoxicillinAnti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
  • Center for Dentistry and Oral Hygiene, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.

ORCID-Profile: Jarno Hakkers, Yvonne C M de Waal, Henny J A Meijer, Gerry M Raghoebar

Förderung

  • Department of Oral and Maxillofacial Surgery
  • University Medical Center Groningen
  • Universitair Medisch Centrum Groningen

Zitieren

APA

Hakkers, J., de Waal, Y. C. M., Gareb, B., Meijer, H. J. A., & Raghoebar, G. M. (2026). Adjunctive Systemic Amoxicillin and Metronidazole Following Surgical Peri‐Implantitis Treatment: A Single‐Blind Randomised Controlled Trial With a 1‐Year Follow‐Up. Journal of Clinical Periodontology, 53(4), 550-561. https://doi.org/10.1111/jcpe.70100

Vancouver

Hakkers J, de Waal YCM, Gareb B, Meijer HJA, Raghoebar GM. Adjunctive Systemic Amoxicillin and Metronidazole Following Surgical Peri‐Implantitis Treatment: A Single‐Blind Randomised Controlled Trial With a 1‐Year Follow‐Up. Journal of Clinical Periodontology. 2026;53(4):550-561. doi:10.1111/jcpe.70100

BibTeX
@article{Hakkers2026,
  author = {Hakkers, Jarno and de Waal, Yvonne C M and Gareb, Barzi and Meijer, Henny J A and Raghoebar, Gerry M},
  title = {Adjunctive Systemic Amoxicillin and Metronidazole Following Surgical Peri‐Implantitis Treatment: A Single‐Blind Randomised Controlled Trial With a 1‐Year Follow‐Up},
  journal = {Journal of Clinical Periodontology},
  year = {2026},
  volume = {53},
  number = {4},
  pages = {550--561},
  doi = {10.1111/jcpe.70100}
}
Kostenlos starten →